Tempus ECG-AF vs RTHawk
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A, Tempus ECG-AF, is designed for predicting the risk of atrial fibrillation using ECG data, focusing on early identification in specific patient populations. In contrast, Tool B, RTHawk, optimizes and accelerates cardiac MRI acquisition and analysis, providing detailed imaging for broader cardiac diagnostics. While both leverage AI in cardiology, their distinct diagnostic modalities and primary clinical applications make them complementary rather than directly comparable.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Tempus ECG-AF is an AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months, supporting earlier identification and follow-up. RTHawk is an AI-driven software that simplifies and accelerates cardiac MRI acquisition, offering one-click automation, real-time imaging, and advanced analysis for improved patient access and diagnostic efficiency.
Tempus ECG-AF is intended for patients 65 years or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery. RTHawk is designed to enhance cardiac MRI for improved patient access and diagnostic efficiency in cardiology and radiology, and provides preliminary measures of left ventricular function.
Tempus ECG-AF detects signs associated with new onset Atrial Fibrillation (AF) within 12 months, with results interpreted in conjunction with other diagnostic information and clinical history. RTHawk provides AI-assisted MRI acquisition, automates standard cardiac views, offers artifact detection, optimizes inversion time, and provides preliminary measures of left ventricular function (ejection fraction, volumes, mass) and 4D flow measurement.
CMS reimbursement is available for Tempus ECG-AF, with CPT codes 0764T and 0765T assigned to APC 5734, at a Medicare rate of $128.90, effective January 1, 2025. The provided information for RTHawk does not specify reimbursement details.
Tempus ECG-AF utilizes an AI-based algorithm trained on over 1.5 million ECGs to analyze 12-lead ECG recordings for AF risk prediction. RTHawk is an AI-driven software that controls the MRI scanner to acquire high-quality, real-time MRI image data and performs post-processing, including optimized image acquisition applications and a pipelined raw data image reconstruction engine.